Earningsreport

Q1/2025 3/31/2025 EPS -0.260 ZacksConsensus -0.360 ActVsEst 0.100 - Beat

Altimmune, Inc.  (ALT) 
NASDAQ:AMEX Investor Relations: altimmune.com/investors